Cours OXIS International, Inc. Other OTC
Actions
US6918294025
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
||
- USD | - |
CA 2024 * | - | CA 2025 * | - | Capitalisation | 10,77 M 9,81 M |
---|---|---|---|---|---|
Résultat net 2024 * | -17 M -15,48 M | Résultat net 2025 * | - | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | - |
PER 2024 * |
-0,72
x | PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 84,13% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Michael Breen
CEO | Chief Executive Officer | 62 | 13/01/21 |
Manu Ohri
DFI | Director of Finance/CFO | 67 | 18/02/22 |
Jeffrey Miller
PRN | Corporate Officer/Principal | - | 14/12/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 78 | 01/05/23 | |
Bruce Wendel
BRD | Director/Board Member | 70 | 11/11/20 |
Rajesh Shrotriya
BRD | Director/Board Member | 79 | 13/01/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+38,23% | 705 Md | |
+32,82% | 583 Md | |
-3,63% | 364 Md | |
+20,13% | 332 Md | |
+5,10% | 291 Md | |
+16,64% | 238 Md | |
-4,13% | 210 Md | |
+10,63% | 209 Md | |
+8,71% | 169 Md |
- Bourse
- Actions
- Action GTBP
- Action